NCT02727738View on ClinicalTrials.gov

Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2015

Conditions
Graves' Disease
Interventions
DIETARY_SUPPLEMENT

Selenium

Selenium 80 mg bid for 90 days

DRUG

Methimazole

Methimazole starting dose depending on FT3 values (15 mg/day or 20 mg/day or 30 mg/day, for FT3 values \<10 pg/ml, 10-15 pg/ml, \>15 pg/ml, respectively) to be tapered by 5 mg/day every 15 days down to values sufficient for FT3 to be normal

Trial Locations (1)

56124

Endocrinology Unit, Pisa

All Listed Sponsors
lead

University of Pisa

OTHER

NCT02727738 - Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole | Biotech Hunter | Biotech Hunter